Relief Therapeutics Holding SA (RLFTF)

OTC Markets
Currency in USD
2.73
+0.14(+5.41%)
Closed·
RLFTF Scorecard
Full Analysis
High shareholder yield
RLFTF is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
2.732.73
52 wk Range
1.107.66
Key Statistics
Edit
Prev. Close
2.73
Open
2.73
Day's Range
2.73-2.73
52 wk Range
1.1-7.66
Volume
189
Average Vol. (3m)
1.92K
1-Year Change
89.58%
Book Value / Share
-
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
RLFTF Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Net income is expected to grow this year
Show more

Relief Therapeutics Holding SA Company Profile

Relief Therapeutics Holding SA, a biopharmaceutical company, engages in identification, development, and commercialization of novel, patent protected products for the treatment of dermatological, metabolic, and pulmonary rare diseases in Switzerland, Europe, North America, and internationally. The company offers SETOFILM/ONDISSOLVE for nausea and vomiting associated with radiotherapy-induced, chemotherapy, and postoperative sequels; ACER-001, a sodium phenylbutyrate for the treatment of urea cycle disorders; and PKU GOLIKE for the dietary management of phenylketonuria. It also develops RLF-100, a synthetic form of vasoactive intestinal peptide for the treatment of acute respiratory distress syndrome and certain chronic lung diseases, including sarcoidosis, berylliosis, and checkpoint inhibitor-induced pneumonitis. In addition, the company develops RLF-TD011, a hypochlorous acid solution for epidermolysis bullosa. Further, it is developing RLF-OD32, a next-generation liquid sapropterin formulation for phenylketonuria. Relief Therapeutics Holding SA was founded in 2013 and is based in Geneva, Switzerland.

Compare RLFTF to Peers and Sector

Metrics to compare
RLFTF
Peers
Sector
Relationship
P/E Ratio
−1.6x−2.9x−0.5x
PEG Ratio
−0.02−0.060.00
Price / Book
-2.0x2.6x
Price / LTM Sales
3.3x6.0x3.0x
Upside (Analyst Target)
-94.4%54.1%
Fair Value Upside
Unlock12.7%8.7%Unlock

Earnings

Latest Release
Apr 10, 2025
EPS / Forecast
-0.50 / --
Revenue / Forecast
1.38M / --
EPS Revisions
Last 90 days

FAQ

What Is the Relief Therapeutics Holding SA (RLFTF) Stock Price Today?

The Relief Therapeutics Holding SA stock price today is 2.73

What Stock Exchange Does Relief Therapeutics Holding SA Trade On?

Relief Therapeutics Holding SA is listed and trades on the OTC Markets stock exchange.

What Is the Stock Symbol for Relief Therapeutics Holding SA?

The stock symbol for Relief Therapeutics Holding SA is "RLFTF."

What Is the Relief Therapeutics Holding SA Market Cap?

As of today, Relief Therapeutics Holding SA market cap is 32.79M.

What Is Relief Therapeutics Holding SA's Earnings Per Share (TTM)?

The Relief Therapeutics Holding SA EPS (TTM) is -1.37.

From a Technical Analysis Perspective, Is RLFTF a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.